Bioray Biotech Co., Ltd (TPEX:7561)
Taiwan · Delayed Price · Currency is TWD 19.60
-0.15 (-0.76%)
May 8, 2026, 1:30 PM CST
Bioray Biotech Market Cap
Bioray Biotech has a market cap or net worth of 606.5 million as of May 8, 2026. Its market cap has decreased by -17.19% in one year.
Market Cap
606.50M
Enterprise Value
447.87M
Revenue
222.73M
Ranking
n/a
PE Ratio
18.81
Stock Price
19.60
Market Cap Chart
Since July 6, 2020, Bioray Biotech's market cap has decreased from 1.94B to 606.50M, a decrease of -68.75%. That is a compound annual growth rate of -18.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 606.50M | -1.91% |
| Dec 31, 2025 | 618.33M | -2.69% |
| Dec 31, 2024 | 635.45M | -31.65% |
| Dec 29, 2023 | 929.63M | 3.17% |
| Dec 30, 2022 | 901.05M | -30.18% |
| Dec 30, 2021 | 1.29B | 56.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GeneFerm Biotechnology | 1.56B |
| InnoPharmax | 1.54B |
| Winston Medical Supply | 1.26B |
| DV Biomed | 1.17B |
| Prince Pharmaceutical | 1.14B |
| Excelsior Biopharma | 1.13B |
| Anxo Pharmaceutical | 1.06B |
| Mediera | 989.30M |